Heimdall Insights

Global Interleukin Inhibitors Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Interleukin Inhibitors Market was valued at $48.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 14.5% CAGR, to an estimated market size of $95.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global interleukin inhibitors market comprises biologic therapies and monoclonal antibodies designed to selectively block specific cytokines (interleukins) involved in immune signaling. These agents are primarily used to manage autoimmune and chronic inflammatory conditions such as psoriasis, rheumatoid arthritis, inflammatory bowel disease (IBD), and asthma, while excluding non-targeted immunosuppressants and traditional small-molecule anti-inflammatories.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Interleukin Inhibitors Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • IL-23 Inhibitors
  • IL-4/13 Inhibitors
  • IL-17 Inhibitors
  • IL-6 Inhibitors
  • Other Inhibitors (IL-1, IL-5, etc.)